European Archives - Page 65 of 1166 - European Medical Journal

Immunotherapy Rechallenge Shows Promise in Advanced Melanoma

New research from the Dutch Melanoma Treatment Registry shows that rechallenging advanced melanoma patients with the immunotherapy combo ipilimumab and nivolumab may offer renewed treatment benefits.

Neuropathic Pain Relief: TCAs Outperform Opioids in Major Review

Tricyclic antidepressants and non-invasive neuromodulation techniques lead updated neuropathic pain treatment guidelines.

Mind-body Exercise Shows Powerful Effects in Type 2 Diabetes Management

Mind-body exercises show promising benefits for type 2 diabetes, improving blood sugar, weight, and heart health markers.

Human Model Sheds Light on Immune Suppression

During the immunosuppressive phase, researchers identified a marked decline in monocyte function and maturation.

New Treatment Improves Platelet Levels in Liver Failure

Compared to controls, the rhTPO group experienced fewer bleeding events and a lower mortality rate.

AI Digital Twins Personalise Chemo Dosing, Reducing Drug Use by 20%

A new AI platform cuts chemo doses by 20% using personalised digital twins in cancer trials.

Early B-Cell Profiles May Predict Remission in Rheumatoid Arthritis

Transitional and CD21⁻ PD-1⁺ B cells identified at diagnosis were linked to better treatment outcomes in early rheumatoid arthritis, according to a spin-off analysis of the NORD-STAR trial.

Hormonal IUDs Linked to Higher Rosacea Risk in Women

A new study reveals a potential link between certain hormonal IUDs and the onset of rosacea, with dermatologists urging awareness of symptoms and treatment options.

Shorter All-Oral TB Regimens Boost Success in Drug-Resistant Cases

Shorter, all-oral bedaquiline-based regimens show 83% success in drug-resistant TB, cutting risk of death and failure.

Dual Index Approach Enhances Detection of Functional Decline in Patients on Haemodialysis

A new study highlights how combining the Geriatric Nutritional Risk Index (GNRI) and Modified Creatinine Index (mCI) significantly improves prediction of functional dependence in hemodialysis patients.